Cost of Revenue in USD of Oncocyte Corp from Q1 2020 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Oncocyte Corp quarterly/annual Cost of Revenue history and change rate from Q1 2020 to Q3 2025.
  • Oncocyte Corp Cost of Revenue for the quarter ending September 30, 2025 was $121K, a 181% increase year-over-year.
  • Oncocyte Corp Cost of Revenue for the twelve months ending September 30, 2025 was $1.96M, a 231% increase year-over-year.
  • Oncocyte Corp annual Cost of Revenue for 2024 was $1.05M, a 5.09% increase from 2023.
  • Oncocyte Corp annual Cost of Revenue for 2023 was $1M, a 13.9% increase from 2022.
  • Oncocyte Corp annual Cost of Revenue for 2022 was $880K, a 26.3% increase from 2021.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Change (%)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Change (%)

Oncocyte Corp Quarterly Cost of Revenue (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $1.96M $121K +$78K +181% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-10
Q2 2025 $1.89M $168K +$136K +425% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-11
Q1 2025 $1.75M $806K +$697K +639% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q4 2024 $1.05M $869K +$460K +112% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-24
Q3 2024 $593K $43K -$116K -73% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-10
Q2 2024 $709K $32K -$137K -81.1% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-11
Q1 2024 $846K $109K -$156K -58.9% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q4 2023 $1M $409K +$131K +47.1% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-24
Q3 2023 $871K $159K -$155K -49.4% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $1.03M $169K -$14K -7.65% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.04M $265K +$160K +152% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $880K $278K -$1.94M -87.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 $2.82M $314K -$546K -63.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $3.37M $183K -$1.17M -86.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $4.54M $105K -$633K -85.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $5.17M $2.22M +$1.5M +210% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-11
Q3 2021 $3.66M $860K +$259K +43.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $3.41M $1.35M +$985K +270% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $2.42M $738K +$565K +327% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $1.86M $716K Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $601K Jul 1, 2020 Sep 30, 2020 10-K 2022-03-11
Q2 2020 $365K Apr 1, 2020 Jun 30, 2020 10-K 2022-03-11
Q1 2020 $173K Jan 1, 2020 Mar 31, 2020 10-K 2022-03-11

Oncocyte Corp Annual Cost of Revenue (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $1.05M +$51K +5.09% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-24
2023 $1M +$122K +13.9% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-24
2022 $880K +$183K +26.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
2021 $697K -$1.16M -62.4% Jan 1, 2021 Dec 31, 2021 10-K 2023-04-12
2020 $1.86M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.